Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for hodgkin's disease

Luigi Salvagno, Mariella Sorarú, Anna Leszl, Haralabos Koussis, Giuseppe De Franchise, Mario V. Fiorentino

Research output: Contribution to journalArticlepeer-review

Abstract

A case of secondary chronic myelogenous leukemia after successful therapy for Hodgkin's disease is reported. The patient was diagnosed as having stage IIIA Hodgkin's disease, at the age of 33. He underwent staging laparosplenectomy and was treated with radiotherapy plus chemotherapy. Forty three months after the diagnosis of Hodgkin's disease, a Philadelphia-positive chronic myelogenous leukemia developed. It required periodic chemotherapy and each time a remission, lasting several months (up to 14 months), was obtained. The disease had an unusually prolonged clinical course, and the blast crisis, of lymphoid type, occurred only 17 years later.

Original languageEnglish
Pages (from-to)177-181
Number of pages5
JournalLeukemia and Lymphoma
Volume16
Issue number1-2
DOIs
Publication statusPublished - 1994

Keywords

  • Chronic myelogenous leukemia
  • Hodgkin's disease
  • Secondary leukemia

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prolonged survival (17 years) in a patient with chronic myelogenous leukemia after therapy for hodgkin's disease'. Together they form a unique fingerprint.

Cite this